Gang Chen
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, MicroRNA in disease regulation, Cancer-related molecular mechanisms research, Myasthenia Gravis and Thymoma
Most-Cited Works
- Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia.(2001)
- → PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project(2018)794 cited
- → Detection of microcystins, a blue-green algal hepatotoxin, in drinking water sampled in Haimen and Fusui, endemic areas of primary liver cancer in China, by highly sensitive immunoassay(1996)750 cited
- → FDA Drug Approval Summary: Gefitinib (ZD1839) (Iressa®) Tablets(2003)573 cited
- → A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee(2020)521 cited
- Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia.(2002)
- → IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy(2020)427 cited
- → New WHO histologic classification predicts prognosis of thymic epithelial tumors(2002)381 cited
- → ITMIG Consensus Statement on the Use of the WHO Histological Classification of Thymoma and Thymic Carcinoma: Refined Definitions, Histological Criteria, and Reporting(2014)319 cited
- → Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer(2024)290 cited